Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that acquires, develops, and sells branded prescription pharmaceuticals. The company focuses on hospital acute care, gastroenterology, and oncology markets. Cumberland promotes its approved products in the United States through its hospital, field, and oncology sales divisions. It also works with international partners to register and provide its medicines to patients in other countries. Cumberland's portfolio of brands approved by the U.S. Food and Drug Administration (FDA) includes: * **Acetadote® (acetylcysteine) injection:** Used to treat acetaminophen poisoning. * **Caldolor® (ibuprofen) injection:** Used to treat pain and fever. * **Kristalose® (lactulose) oral solution:** A prescription laxative for constipation. * **Sancuso® (granisetron) transdermal:** Prevents nausea and vomiting in patients undergoing certain chemotherapy treatments. * **Vaprisol® (conivaptan) injection:** Raises serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia. * **Vibativ® (telavancin) injection:** Treats certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, and complicated skin and skin structure infections. * **Tacilia® (omeprazole, amoxicillin, and rifabutin) oral capsule:** Treats H. pylori infection. The company has also reported results from a clinical study of its ifetroban product candidate for cardiomyopathy associated with Duchenne muscular dystrophy (DMD).